Tuesday, December 10, 2013 | 8:30 AM - 4:30 PM
Speakers: Frank M. LaFerla (University of California, Irvine), Sylvain E. Lesné (University of Minnesota), Bingwei Lu (Stanford University School of Medicine), Lennart Mucke (Gladstone Institute of Neurological Disease), Ralph A. Nixon (Nathan Kline Institute), Franck Polleux (Columbia University), Terrence Town (University of Southern California), Tony Wyss-Coray (Stanford University School of Medicine)
Organizers: Ken Jones (Forest Research Institute), Robert Martone (Covance Biomarker Center of Excellence),
Robert B. Nelson (Lundbeck Research USA), Jennifer Henry (The New York Academy of Sciences)
This symposium explores how efforts to better integrate our understanding of neuritic plaques and neurofibrillary tangles—the two hallmark pathologies of Alzheimer's disease—are leading to a 'truce' between former rivals in the quest for therapies.
Wednesday, December 11, 2013 | 12:00 PM - 4:00 PM
Speakers: T. Eric Ballard (Pfizer Worldwide Research and Development), Joseph M. Fox (University of Delaware), Howard C. Hang (The Rockefeller University), Minkui Luo (Memorial Sloan-Kettering Cancer Center), Lisa Shah (SUNY Stony Brook)
Innovations in chemistry often lead to breakthroughs in biology and medicine. This symposium highlights advances in bioorthogonal chemistry, affording opportunities to explore biology and facilitating the synthesis of diagnostics and therapeutics.
Wednesday, December 11, 2013 | 7:00 PM - 8:30 PM
Featuring: Peter Fenwick, Kevin Nelson, Mary Neal, Sam Parnia
Moderator: Steve Paulson
What happens when we die? Recent medical advances have led to increased reports of "out of body" or "near death" experiences. Can these experiences be explained, and what can we learn from the transformative accounts of those who have nearly died?
Thursday, December 12, 2013 | 8:30 AM - 5:00 PM
Keynote Speaker: Barbara Burlingame, Food and Agriculture Organization of the United Nations
Speakers: David Berry (Flagship Ventures), Jessica Fanzo (Columbia University), Gabor Forgacs (University of Missouri-Columbia), Dennis Miller (Cornell University), Prabhu Pingali (Cornell University), Mark Post (Maastricht University), Charles Schasteen (DuPont Nutrition & Health), Jean Steiner (United States Department of Agriculture), Josip Simunovic (North Carolina State University), Anna Thalacker-Mercer (Cornell University), Irvin Widders (Michigan State University), Guoyao Wu (Texas A&M University)
Studying the protein supply chain to improve dietary quality.
Tuesday, January 28, 2014 | 8:30 AM - 4:30 PM
Speakers: Ho Sung Cho (Ambrx), Nahor Haddish-Berhane (Pfizer), Sara Hurvitz (UCLA Medical Center), Omar Kabbarah (Genentech Inc.), Peter D. Senter (Seattle Genetics, Inc.), Dhaval K. Shah (The State University of New York at Buffalo), and Puja Sapra (Pfizer)
Antibody-drug conjugates (ADCs) promise safer, more effective therapies than standard anti-cancer drugs. This symposium highlights linker-payload and coupling chemistries, ADC development, biomarker and patient selection, and regulatory perspectives.
Monday, December 2, 2013 | 7:00 PM - 8:30 PM
Speakers: Lawrence Brandt (Albert Einstein College of Medicine), Martin Blaser (New York University Medical Center), Maria Gloria Dominguez-Bello (New York University)
Join us to learn about our basic microbial ecology; how our gut bacteria are linked to diabetes and obesity; how newborns are first colonized by bacteria; and how treatments are changing people's lives one single-celled organism at a time.
Monday, December 2, 2013 | 1:30 PM - 4:30 PM
Speakers: Emily Foley (Memorial Sloan-Kettering Cancer Center), Benjamin Garcia (University of Pennsylvania), Rob Martienssen (Cold Spring Harbor Laboratory), Mai Sato (Gautier Lab, Columbia University), Agata Smogorzewska (The Rockefeller University), Yu Zhang (Jasin Lab, Memorial Sloan-Kettering Cancer Center)
Organizers: John Petrini (Memorial Sloan-Kettering Cancer Center), Susan Smith (NYU Langone Medical Center), Lorraine Symington (Columbia University Medical Center)
The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.
Thursday, November 21, 2013 | 8:00 AM - 5:00 PM
Keynote Speaker: Sally Tinkle (IDA/Science and Technology Policy Institute)
Featured Speakers: Yechezkel (Chezy) Barenholz (Hebrew University-Hadassah Medical School), Raj Bawa (Bawa Biotech LLC and Rensselaer Polytechnic Institute), Gerrit Borchard (University of Geneva, University of Lausanne), Ricardo Carvajal (Hyman, Phelps & McNamara, P.C.), Neil Desai (Abraxis Bioscience, A wholly owned subsidiary of Celgene Corporation), Rogério Gaspar (University of Lisbon), Patrick Hunziker (University Hospital Basel), Laurent Levy (Nanobiotix), Scott E. McNeil (Nanotechnology Characterization Laboratory – Frederick National Laboratory for Cancer Research), Stefan Mühlebach (Vifor Pharma Ltd. and University of Basel), Ritu Nalubola (US Food and Drug Administration), Lawrence Tamarkin (Cytimmune)
Explore regulatory challenges in the nascent field of nanomedicines including the relevance and adequacy of existing frameworks, availability and expertise of regulators, and safety concerns.
Thursday, November 14, 2013 | 12:00 PM - 4:00 PM
Keynote Speaker: Nancy J. Cox (Centers for Disease Control and Prevention)
Speakers: Kathy Coelingh (MedImmune), Manon M. J. Cox (Protein Sciences), Ruben Donis (Centers for Disease Control and Prevention), Philip R. Dormitzer (Novartis Vaccines and Diagnostics), David P. Greenberg (Sanofi Pasteur US)
Evolution of the influenza virus and emergence of new viruses from animals pose a continuing challenge. H7N9, H1N1pdm and H5N1 are all sources of ongoing concern. Explore quadrivalent vaccines, efforts to boost efficacy, and recent FDA approvals.
Organizers: Mercedes Beyna (Pfizer), Robert Martone (Covance Biomarker Center of Excellence), Nilufer Seth (Pfizer), Richard Snyder (Covance Biomarker Center of Excellence), and Jennifer Henry (The New York Academy of Sciences)
This eBriefing looks at how symbioses between humans and the gut microbiome impact drug metabolism, development, and a variety of disease states.
Keynote Speakers: Alfred W. Sandrock Jr. (Biogen Idec) and Declan R. Walsh (Deferno Trust)
This eBriefing reviews new basic science and clinical findings on the pathogenesis, mitigation, cure, and risk stratification of PML.
Edited by Annals of the New York Academy of Sciences
In this Annals volume an eclectic group of experts shares their thoughts and opinions on the nature and function of consciousness in relation to behavior, ethics, creativity, music, and mindfulness.
Featured Speaker: David Julius (University of California, San Francisco)
This eBriefing features David Julius, the recipient of the 2013 Dr. Paul Janssen Award for Biomedical Research for his role in discovering a mechanism for nociception and thermosensation. Recent research on pain is also described.
Good oral hygiene helps prevent tooth decay and gum disease, but the health of your mouth may have a big impact on the rest of your body too—especially if you have diabetes.
September 10, 2010
Can we all be wise old owls? Science journalist Stephen Hall and neuroscientist Andre Fenton dissect what we call wisdom, from the neurons in our brain, to the social constructs behind it.
Neuroscientist Richard Restak thinks with the right mental exercises, our brains can be much better. Today he teams with writer Susan Orlean to talk about our brainy potential.
With our economy a shambles and our environment threatened, is there any reason to be optimistic about the future? Matt Ridley says there's scientific proof to say we should be.
March 2, 2010
Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.
February 23, 2010
Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.
October 27, 2009
What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.
April 28, 2009
Protein kinases play a key role in almost every major pathway in eukaryotic cells. Structural approaches, including a new method called fragment-based drug design, are identifying potential targets against diseases including cancer.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.